ZA849718B - 1,5-benzoxathiepin derivatives,their production and use - Google Patents

1,5-benzoxathiepin derivatives,their production and use

Info

Publication number
ZA849718B
ZA849718B ZA849718A ZA849718A ZA849718B ZA 849718 B ZA849718 B ZA 849718B ZA 849718 A ZA849718 A ZA 849718A ZA 849718 A ZA849718 A ZA 849718A ZA 849718 B ZA849718 B ZA 849718B
Authority
ZA
South Africa
Prior art keywords
production
benzoxathiepin
derivatives
benzoxathiepin derivatives
Prior art date
Application number
ZA849718A
Other languages
English (en)
Inventor
Hirosada Sugihara
Minoru Hirata
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA849718B publication Critical patent/ZA849718B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA849718A 1983-12-14 1984-12-13 1,5-benzoxathiepin derivatives,their production and use ZA849718B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1983/000436 WO1985002617A1 (en) 1983-12-14 1983-12-14 1,5-benzoxathiepin derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ZA849718B true ZA849718B (en) 1986-08-27

Family

ID=13790100

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA849718A ZA849718B (en) 1983-12-14 1984-12-13 1,5-benzoxathiepin derivatives,their production and use

Country Status (4)

Country Link
JP (1) JPS60142979A (enrdf_load_stackoverflow)
SU (1) SU1438611A3 (enrdf_load_stackoverflow)
WO (1) WO1985002617A1 (enrdf_load_stackoverflow)
ZA (1) ZA849718B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229467A1 (en) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin derivatives, their production and use
FR2908132B1 (fr) * 2006-11-08 2008-12-19 Pierre Fabre Medicament Sa Procede de synthese du n-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Also Published As

Publication number Publication date
JPS60142979A (ja) 1985-07-29
JPH043397B2 (enrdf_load_stackoverflow) 1992-01-23
SU1438611A3 (ru) 1988-11-15
WO1985002617A1 (en) 1985-06-20

Similar Documents

Publication Publication Date Title
DE3463384D1 (en) Oligonucleotide derivatives and production thereof
DE3574379D1 (en) Tetrahydrophtalimides, and their production and use
EP0149884A3 (en) 5-pyridyl-1,3-thiazole derivatives, their production and use
DE3563627D1 (en) Triazolopyridazines, and their production and use
GR81098B (en) Derivatives of 2,2 - iminodisethanol
DE3262455D1 (en) Diphenoxypropane derivatives, their production and use
EP0206435A3 (en) 2,4-dihalo-5-substituted phenylhydrazines and their production and use
EP0186190A3 (en) Benzimidazole derivatives, and their production and use
DE3466688D1 (en) Benzimidazole derivatives, and their production and use
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
DE3476542D1 (en) Carbamoyltriazoles, and their production and use
DE3568435D1 (en) 2-acetoacetylglycerol derivatives, their production and use
DE3476656D1 (en) Derivatives of beta-amino-gamma-trimethylammonio-butyrate, their production and use
DE3160724D1 (en) N'-phenyl-n-methylurea derivatives, their production and use
ZA857448B (en) Thiazolidinedione derivatives,their production and use
DE3460445D1 (en) Pyridotriazolium compounds, and their production and use
DE3476800D1 (en) 1,2,4-triazolylpropanols, and their production and use
ZA832742B (en) 1-sulfo-2-azetidinone derivatives,their production and use
DE3479657D1 (en) 1-normonyl derivatives, processes and use
DE3473876D1 (en) Benzopyran-4-on derivatives and their production
ZA847781B (en) Fluoralkylated carbapeneme derivatives,processes for the production and their use
ZA849718B (en) 1,5-benzoxathiepin derivatives,their production and use
EP0178909A3 (en) Guanidylfungin derivatives and their production
DE3261765D1 (en) Aminonaphthacene derivatives and their production
DE3267439D1 (en) Trifluoromethanesulfonanilides, and their production and use